Pramipexole for Binge Eating Disorder

NCT01106053 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participants were recruited and study has been closed.

Conditions

Binge Eating Disorder

Interventions

DRUG: Pramipexole

Sponsor

Neuropsychiatric Research Institute, Fargo, North Dakota